Genetic aberrations such as somatic mutations (specifically NOTCH1 mutation) and/or CNVs have a serious influence on the early appearance of clinical symptoms of CLL patients, and therefore might trigger the clinical evolution of the disease. This evidence concerns the gene NOTCH1 and B-cell chronic lymphocytic leukemia.